Astrana Health Inc (ASTH)
Days of sales outstanding (DSO)
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
DSO | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
Based on the provided data, Astrana Health Inc's days of sales outstanding (DSO) information is not available for the periods from March 31, 2020, to December 31, 2024. DSO is a financial ratio that measures the average number of days a company takes to collect payment after a sale has been made. As the DSO values are indicated as "— days" for all the periods in the data, it is not possible to analyze or interpret the efficiency of Astrana Health Inc in collecting its accounts receivable within a specific time frame. A low DSO typically indicates that the company is efficient in collecting payments, while a high DSO may suggest potential issues with accounts receivable management or liquidity. Further information or specific data points would be needed to assess the effectiveness of Astrana Health Inc's accounts receivable management and cash flow generation over time.
Peer comparison
Dec 31, 2024